Datasets

3 datasets

HealthData.Gov

Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis

Background The pathogenetic mechanisms that underlie the interstitial lung disease cryptogenic fibrosing alveolitis (CFA) may involve an immunological reaction to unidentified antigens in the lung, resulting in tissue…

HTML

Updated Oct 29, 2026

HealthData.Gov

Tumour necrosis factor-α production in fibrosing alveolitis is macrophage subset specific

Background Previous studies have revealed that tumour necrosis factor (TNF)-α is upregulated in fibrosing alveolitis (FA) in humans. The aim of this study was to compare the TNF-α secretory profile of alveolar…

HTML

Updated Oct 29, 2026

HealthData.Gov

Anti-cytokine therapy in fibrosing alveolitis: where are we now?

Idiopathic pulmonary fibrosis (IPF) is a condition that has a poor prognosis, with a median survival of 4-5 years irrespective of treatment. Ziesche et al (N Engl J Med 1999, 341: 1264-1269) describe an open randomised…

HTML

Updated Oct 29, 2026